The policy has relaxed supervision of online pharmacies and is gradually setting off a wave of capital introduction. Recently, the reporter was informed that Jianyi Network, a pharmaceutical e-commerce platform owned by the China Resources Group, completed Series A financing with a financing amount of 300 million yuan and became the first online pharmacy to be favored by capital. Demetdent announced the release of the our company`s wet/dry milling machine. It was added to the Demetdent family of dental milling devices in answer to our lab and dental users need for a wet-milling option to handle many of the new brands and materials. The wet/dry milling machine fills a gap in many dental restoration workflows, giving laboratories the added flexibility of milling glass ceramic, composite resin materials that are becoming increasingly popular in the industry due to their high translucency, increased flexural strength and hardness, and overall aesthetic value for inlay/onlays. Cerec Machine,Dental Machine,Dental Milling Machine,Teeth Cleaning Machine Shandong Carved Intelligent Technology Group Co.,Ltd , https://www.demetdent.com
Zhang Yong, director of the Chinese pharmacy e-commerce research center, told the Daily Economic News reporter that the financing of the pharmaceutical e-commerce industry is breaking ice and will inevitably boost the morale of the entire industry. In the future, more online pharmacies are expected to obtain investment and the industry will usher in capital. Acceleration period.
China Resources Group Pharmaceutical E-Commerce Obtains Financing
On May 28, the State Food and Drug Administration issued the "Administrative Measures on Internet Food and Drug Administration Supervision (Draft for Solicitation of Comments)", proposing that Internet drug dealers be allowed to sell prescription drugs by prescription. Many brokers are optimistic about the development of medical e-commerce. In recent days, Jianyi.com became the first pharmaceutical e-commerce company to be favored by capital.
According to public information, Jianyi.com is China Resources Group's pilot pharmaceutical e-commerce company. According to data from the Chinese pharmacy e-commerce research center, Jianyi.com's sales volume in 2013 was RMB 380 million, ranking first in China's pharmaceutical B2C sales rankings.
He Tao, general manager of China Resources Jianyi Network, told the Daily Economic News reporter that Jianyi.com's investment partner is Shanghai International Venture Capital, with an initial investment of 110 million yuan. Last year, a number of domestic and foreign investment agencies began to contact Jianyi.com, based on the consensus of both parties on Jianyi.com's business model and business layout, they finally chose Shanghai International Venture Capital.
He Tao told reporters that the funds to be used will be mainly used for the construction of data management centers, O2O systems, and call centers. It is used to promote the transformation of Jianyi.com from an e-commerce company to a health management company. The company plans to achieve 100 years in about 4 years. Billion sales scale.
Pharmaceutical market pattern or change
According to data from the China Online Drugstore Council, the share of online pharmacies in the pharmaceutical market has increased year by year, and is expected to account for 1.2% in 2013. However, compared with the US e-commerce accounted for about 30% of the pharmaceutical market share, the domestic pharmaceutical e-commerce has a lot of room for improvement.
U.S. pharmaceutical researcher Ji Xu of UBS Securities stated that the scale of pharmaceutical e-commerce in 2013 was only over 4 billion yuan, of which sales mainly consisted of medical devices, birth control products, health products such as blood pressure meters, and drug sales were less than 400 million yuan. yuan.
"As a standard commodity, drugs are more suitable for online sales because of their essential nature. With substantial progress in prescription drug and other policies, medical e-commerce providers will be able to replicate the e-commerce growth curve in other commodity areas." .
In addition, letting go of prescription drugs means that the market space for pharmaceutical e-commerce will expand from the OTC market of 200 billion yuan to the entire pharmaceutical market with a scale of nearly trillion yuan. In particular, the popularity of the prescription drug market will have a profound impact on the entire healthcare industry chain.
Citic Securities Research reported that due to the excessive circulation of traditional medicine sales, and the increase in the prices of medicines, resulting in high drug prices, the emergence of pharmaceutical e-commerce will greatly reduce circulation and reduce drug prices.